Imagin Medical Inc. (IMEXF)

[lithiumjr]

News! Imagin releases i/Blue imaging trial patient criteria

2017-10-19 11:33 ET - News Release


Mr. Jim Hutchens reports

IMAGIN MEDICAL ANNOUNCES CLINICAL RESEARCH CRITERIA 10.19.17

Imagin Medical Inc. has released the recruitment criteria for the upcoming research study at the University of Rochester Medical Center.

The pilot study, entitled Near Infrared Fluorescence Imaging for Bladder Cancer Detection, is sponsored by Dr. Edward Messing, chair of urology at the University of Rochester Medical Center, and the study's principal investigator. The study is registered on the National Institutes of Health (NIH) website.

Criteria to participate in the study include men and women 18 years or older, of either sex and any racial or ethnic origin, who are scheduled for a transurethral resection of bladder tumor (TURBT) in the operating room resulting from either a new diagnosis of a potentially malignant bladder mass or a recurrent tumor.

The procedure to remove the suspicious mass will remain the same, that is, TURBT; it is the method to detect the cancerous cells to be removed that will differ significantly. The i/Blue imaging system is expected to highlight the cancerous cells in less than 10 minutes versus the full hour required by current systems, leading to a substantial reduction in the time and cost of staff and facilities.